You have 9 free searches left this month | for more free features.

Adenosine Pathway

Showing 1 - 25 of 3,177

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Stereotactic body radiotherapy (SBRT)
  • +4 more
  • New York, New York
    Columbia University Irving Medical Center
Sep 15, 2023

Solid Tumor, Adult Trial in Korea, Republic of, United States (TTX-030, budigalimab and mFOLFOX6, TTX-030, budigalimab and

Active, not recruiting
  • Solid Tumor, Adult
  • TTX-030, budigalimab and mFOLFOX6
  • +7 more
  • Scottsdale, Arizona
  • +31 more
Oct 18, 2022

Diarrhea-predominant Irritable Boewl Syndrome Trial in Beijing (Modified Gegen Qinlian Decoction)

Recruiting
  • Diarrhea-predominant Irritable Boewl Syndrome
  • Modified Gegen Qinlian Decoction
  • Beijing, Beijing, China
    Xiyuanhospital
Mar 13, 2020

Myocardial Infarction, Myocardial Fibrosis, Myocardial Remodeling, Ventricular Trial in Messina (P2Y12 Potent Inhibitor +

Recruiting
  • Myocardial Infarction
  • +2 more
  • P2Y12 Potent Inhibitor + Aspirin for STEMI patients
  • Clopidogrel + Aspirin for CCS patients
  • Messina, Italy
    AOU Policlinico G. Martino
Jan 21, 2023

Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)

Not yet recruiting
  • Oligometastatic Prostate Cancer
  • New York, New York
    Columbia University Irving Medical Center / NewYork-Presbyterian
Jun 14, 2023

Pancreatic Cancer Trial (TTX-030, nab-paclitaxel and gemcitabine, TTX-030, budigalimab, nab-paclitaxel and gemcitabine,

Not yet recruiting
  • Pancreatic Cancer
  • TTX-030, nab-paclitaxel and gemcitabine
  • +2 more
  • (no location specified)
Nov 3, 2023

Ulcerative Colitis Trial in Beijing (Modified Gegen Qinlian Decoction)

Recruiting
  • Ulcerative Colitis
  • Modified Gegen Qinlian Decoction
  • Beijing, Beijing, China
    Xiyuanhospital
Oct 11, 2019

Colorectal Cancer, Gastric Cancer, Hepatocellular Carcinoma Trial (TT-4)

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • (no location specified)
Apr 26, 2022

Advanced Solid Tumor Trial in Canada, United States (SRF617, Gemcitabine, Albumin-Bound Paclitaxel)

Active, not recruiting
  • Advanced Solid Tumor
  • Duarte, California
  • +9 more
Nov 28, 2022

Cancer in Inherited Bone Marrow Failure Syndromes

Recruiting
  • Diamond Blackfan Anemia
  • +4 more
    • Bethesda, Maryland
    • +1 more
    Jan 24, 2023

    Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

    Not yet recruiting
    • Breast Cancer
    • Marseille, France
      Institut Paoli Calmettes
    Aug 9, 2023

    Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in United States (SRF617, etrumadenant, zimberelimab)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Prostate Cancer
    • Miami, Florida
    • +6 more
    Jun 13, 2022

    Well Differentiated Pancreatic Endocrine Tumor Trial in Milano (Everolimus plus Octreotide LAR plus Metformin)

    Active, not recruiting
    • Well Differentiated Pancreatic Endocrine Tumor
    • Everolimus plus Octreotide LAR plus Metformin
    • Milano, Italy
      Fondazione IRCCS Istituto Tumori Milano
    Sep 3, 2021

    Soft-tissue Sarcoma Trial in Philadelphia (TAK-228)

    Terminated
    • Soft-tissue Sarcoma
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Sep 19, 2022

    Heart Failure With Preserved Ejection Fraction, Diabete Type 2 Trial in Cairo (Metformin)

    Not yet recruiting
    • Heart Failure With Preserved Ejection Fraction
    • Diabete Type 2
    • Cairo, Egypt
      clinical research uint- El-sheikh zayed specialized hospital SMC
    Oct 8, 2023

    Cough Trial (device, diagnostic test, procedure)

    Not yet recruiting
    • Cough
    • Adenosine triphosphate (ATP) solution inhalation from nebuliser
    • +7 more
    • (no location specified)
    Jan 26, 2023

    NSCLC Trial in Marseille (Durvalumab (MEDI4736), Monalizumab (IPH2201), Oleclumab (MEDI9447))

    Recruiting
    • Non-small Cell Lung Cancer
    • Durvalumab (MEDI4736)
    • +5 more
    • Marseille, France
      Assistance Publique Hopitaux de Marseille
    Sep 21, 2022

    Breast Cancer, Breast Tumors, Cancer of Breast Trial in New York (Metformin, Atorvastatin, Breast surgery)

    Active, not recruiting
    • Breast Cancer
    • +2 more
    • New York, New York
      Columbia University Medical Center - Herbert Irving Cancer Cente
    Aug 16, 2022

    Inhaled Nitric Oxide Responsiveness in Patients With PPHN

    Withdrawn
    • PPHN
    • Hypoxic Respiratory Failure
      • (no location specified)
      Sep 12, 2023

      Cardiac Tissue in Postnatal Development

      Recruiting
      • Congenital Heart Disease
      • Tetralogy of Fallot
        • Atlanta, Georgia
          Emory University School of Medicine
        Jun 21, 2022

        Syncope Trial in Milan (adenosine dosage)

        Completed
        • Syncope
        • adenosine dosage
        • Milan, MI, Italy
          IRCCS Istituto Auxologico Italiano
        Mar 23, 2023

        Efficacy and Adverse Effects of Olaparib in Ovarian Cancer.

        Enrolling by invitation
        • Ovarian Cancer
          • Xi'an, Shaanxi, China
            The First Affliated Hospital of Xi'an Jiaotong University
          Mar 23, 2022

          Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)

          Recruiting
          • Advanced Solid Tumor
          • +18 more
          • PT199
          • Anti-PD-1 monoclonal antibody
          • Huntersville, North Carolina
          • +2 more
          Aug 10, 2022

          Respiratory Failure Trial in Boston (Normoxia with Normocarbia, Normoxia with Hypercarbia, Hyperoxia with Normocarbia)

          Terminated
          • Respiratory Failure
          • Normoxia with Normocarbia
          • +3 more
          • Boston, Massachusetts
            Beth Israel Deaconess Medical Center
          Mar 7, 2022

          Cough Trial in Parkville (Adenosine Triphosphate, Capsaicin, Functional Brain Imaging)

          Completed
          • Cough
          • Adenosine Triphosphate
          • +2 more
          • Parkville, Victoria, Australia
            The University of Melbourne
          Jun 10, 2022